Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Frontiers in Microbiology|August 30, 2021
Development, Phenotypic Characterization and Genomic Analysis of a <i>Francisella tularensis</i> Panel for Tularemia Vaccine TestingBeth A Bachert, Joshua B Richardson, Kevin D Mlynek, et al.
Microbial Pathogenesis|April 29, 2021
Comparison of three non-human primate aerosol models for glanders, caused by Burkholderia malleiDavid M Waag, Taylor B Chance, Sylvia R Trevino, et al.
Frontiers in Microbiology|September 5, 2022
Layered and integrated medical countermeasures against <i>Burkholderia pseudomallei</i> infections in C57BL/6 miceChristopher P Klimko, Jennifer L Shoe, Nathaniel O Rill, et al.
Vaccines|March 6, 2021
Protection Elicited by Attenuated Live <i>Yersinia pestis</i> Vaccine Strains against Lethal Infection with Virulent <i>Y. pestis</i>Christopher K Cote, Sergei S Biryukov, Christopher P Klimko, et al.
Antibodies (Basel, Switzerland)|May 23, 2023
Polyclonal Antibodies Derived from Transchromosomic Bovines Vaccinated with the Recombinant F1-V Vaccine Increase Bacterial Opsonization In Vitro and Protect Mice from Pneumonic PlagueSergei S Biryukov, Hua Wu, Jennifer L Dankmeyer, et al.
Human Vaccines & Immunotherapeutics|June 8, 2023
Functional assays to screen and select monoclonal antibodies that target Sergei S Biryukov, Nathaniel O Rill, Christopher P Klimko, et al.
Frontiers in Immunology|September 13, 2021
Impact of Toll-Like Receptor-Specific Agonists on the Host Immune Response to the <i>Yersinia pestis</i> Plague rF1V VaccineSergei Biryukov, Jennifer L Dankmeyer, Zain Shamsuddin, et al.
Vaccines|November 27, 2021
Predictive and Experimental Immunogenicity of <i>Burkholderia</i> Collagen-like Protein 8-Derived AntigensMegan E Grund, Eliza Kramarska, Soo Jeon Choi, et al.
Plos One|October 20, 2018
A fixed moderate-dose combination of tiletamine+zolazepam outperforms midazolam in induction of short-term immobilization of ball pythons (Python regius)Lynn J Miller, David P Fetterer, Nicole L Garza, et al.
The Journal of Infectious Diseases|July 23, 2020
Clindamycin Protects Nonhuman Primates Against Inhalational Anthrax But Does Not Enhance Reduction of Circulating Toxin Levels When Combined With CiprofloxacinNicholas J Vietri, Steven A Tobery, Donald J Chabot, et al.
Pageof 4